Tutorials
VitaSpring Biomedical Co Ltd logo

VitaSpring Biomedical Co Ltd

$ 16.50 0 (0%) 10:08 PM EST
P/E:
2,750.00
P/B:
1,833.33
Market Cap:
$ 3.41B
Enterprise V:
$ 3.41B
Volume:
-
Avg Vol (2M):
755.00
Volume:
-
Market Cap $:
3.41B
PE Ratio:
2,750.00
Avg Vol (2-Month):
755.00
Enterprise Value $:
3.41B
PB Ratio:
1,833.33
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

VitaSpring Biomedical Co Ltd
NAICS : 325411 SIC : 2833
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
Compare
Compare
PTCT HRMY VIR BEAM ROCO:6550 CVAC RLAY SHSE:688520 INSM BOM:539268
Traded in other countries / regions
VSBC.USA
Description
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.
Name Current Vs Industry Vs History
Cash-To-Debt 0.19
Equity-to-Asset 0.7
Debt-to-Equity 0.22
Debt-to-EBITDA 0.25
Interest Coverage 1648
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2542.5
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year FCF Growth Rate -100

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 99.82
9-Day RSI 98.83
14-Day RSI 97.43
6-1 Month Momentum % 17.86
12-1 Month Momentum % 4.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.78
Quick Ratio 5.78
Cash Ratio 0.21
Days Inventory 12.6
Days Sales Outstanding 140.91
Days Payable 109.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -55.9

Financials

VSBC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:VSBC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.569
EPS (TTM) ($) 0.006
Beta 0
Volatility % 38.59
14-Day RSI 97.43
14-Day ATR ($) 0.047556
20-Day SMA ($) 16.5
12-1 Month Momentum % 4.43
52-Week Range ($) 10 - 19.5
Shares Outstanding (Mil) 206.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VitaSpring Biomedical Co Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More